DK160825C - Analogifremgangsmaade til fremstilling af 2-(halogensubstitueret pyridyl)-1,3-bis(1h-1,2,4-triazol-1-yl)propan-2-ol-derivater eller farmaceutisk acceptable syreadditionssalte deraf - Google Patents

Analogifremgangsmaade til fremstilling af 2-(halogensubstitueret pyridyl)-1,3-bis(1h-1,2,4-triazol-1-yl)propan-2-ol-derivater eller farmaceutisk acceptable syreadditionssalte deraf

Info

Publication number
DK160825C
DK160825C DK266083A DK266083A DK160825C DK 160825 C DK160825 C DK 160825C DK 266083 A DK266083 A DK 266083A DK 266083 A DK266083 A DK 266083A DK 160825 C DK160825 C DK 160825C
Authority
DK
Denmark
Prior art keywords
triazol
propan
bis
halogen
procedure
Prior art date
Application number
DK266083A
Other languages
Danish (da)
English (en)
Other versions
DK266083D0 (da
DK266083A (da
DK160825B (da
Inventor
Kelvin Cooper
Kenneth Richardson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK266083D0 publication Critical patent/DK266083D0/da
Publication of DK266083A publication Critical patent/DK266083A/da
Publication of DK160825B publication Critical patent/DK160825B/da
Application granted granted Critical
Publication of DK160825C publication Critical patent/DK160825C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28Halogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK266083A 1982-06-12 1983-06-10 Analogifremgangsmaade til fremstilling af 2-(halogensubstitueret pyridyl)-1,3-bis(1h-1,2,4-triazol-1-yl)propan-2-ol-derivater eller farmaceutisk acceptable syreadditionssalte deraf DK160825C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8217114 1982-06-12
GB8217114 1982-06-12

Publications (4)

Publication Number Publication Date
DK266083D0 DK266083D0 (da) 1983-06-10
DK266083A DK266083A (da) 1983-12-13
DK160825B DK160825B (da) 1991-04-22
DK160825C true DK160825C (da) 1991-10-14

Family

ID=10531001

Family Applications (1)

Application Number Title Priority Date Filing Date
DK266083A DK160825C (da) 1982-06-12 1983-06-10 Analogifremgangsmaade til fremstilling af 2-(halogensubstitueret pyridyl)-1,3-bis(1h-1,2,4-triazol-1-yl)propan-2-ol-derivater eller farmaceutisk acceptable syreadditionssalte deraf

Country Status (16)

Country Link
US (1) US4510148A (fi)
EP (1) EP0097014B1 (fi)
JP (1) JPS5962587A (fi)
KR (1) KR870000358B1 (fi)
AT (1) ATE24909T1 (fi)
AU (1) AU542450B2 (fi)
CA (1) CA1238909A (fi)
DE (1) DE3369137D1 (fi)
DK (1) DK160825C (fi)
ES (1) ES8407488A1 (fi)
FI (1) FI74465C (fi)
GR (1) GR77534B (fi)
IE (1) IE55233B1 (fi)
IL (1) IL68945A (fi)
PH (1) PH21493A (fi)
PT (1) PT76846B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8305377D0 (en) * 1983-02-25 1983-03-30 Pfizer Ltd Antifungal agents
GB8306351D0 (en) * 1983-03-08 1983-04-13 Ici Plc Azole fungicides
US4992454A (en) * 1983-03-16 1991-02-12 Pfizer Inc. Antifungal 1,3-bis (1H-1,2,4-triazol-1-yl)-2-aryl butan-2-ols and derivatives thereof
DK159205C (da) * 1983-03-16 1991-03-04 Pfizer Bis(triazol)alkanol-forbindelser, anvendelse af disse, farmaceutiske praeparater og landbrugsfungicider indeholdende disse og fremgangsmaade til behandling af planter eller froe, som har en svampeinfektion
GB8313235D0 (en) * 1983-05-13 1983-06-22 Pfizer Ltd Antifungal agents
IE58738B1 (en) * 1984-09-05 1993-11-03 Ici Plc Antifungal azole compounds
GB8819308D0 (en) * 1988-08-13 1988-09-14 Pfizer Ltd Triazole antifungal agents
GB9002375D0 (en) * 1990-02-02 1990-04-04 Pfizer Ltd Triazole antifungal agents
US5068333A (en) * 1990-03-07 1991-11-26 Pfizer Inc. 6-chloro-3,4-dihydro-pyrano [2,3-b]pyridines having the R configuration
NZ270418A (en) * 1994-02-07 1997-09-22 Eisai Co Ltd Polycyclic triazole & imidazole derivatives, antifungal compositions
JP2002519346A (ja) * 1998-06-30 2002-07-02 ニューロゲン コーポレイション 1−(ベンゾチアゾール−2−イル)−4−(1−フェニルメチル)ピペラジン:ドーパミン受容体サブタイプ特異リガンド
US6291463B1 (en) 1998-06-30 2001-09-18 Neurogen Corporation 1-(Benzothiazol-2-yl)-4-(1-phenylmethyl) piperazines: dopamine receptor subtype specific ligands
MX2015014365A (es) * 2013-04-12 2015-12-07 Bayer Cropscience Ag Derivados de triazol novedosos.
JP2017513848A (ja) 2014-04-15 2017-06-01 ダウ アグロサイエンシィズ エルエルシー 殺真菌剤としての金属酵素阻害剤化合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3658813A (en) * 1970-01-13 1972-04-25 Janssen Pharmaceutica Nv 1-(beta-aryl-beta-(r-oxy)-ethyl)-imidazoles
DE2738725A1 (de) * 1977-08-27 1979-03-08 Basf Ag Azolylalkohole
DE2926280A1 (de) * 1979-06-29 1981-01-08 Basf Ag Fungizide alpha -triazolylglykolderivate, ihre herstellung und verwendung
GB2078719B (en) * 1980-06-02 1984-04-26 Ici Ltd Heterocyclic compounds
EP0046337A3 (en) * 1980-08-20 1982-09-15 Imperial Chemical Industries Plc Triazole compounds, a process for preparing them, their use as plant and pharmaceutical fungicides and as plant growth regulators and compositions containing them
JPS5758671A (en) * 1980-09-25 1982-04-08 Ishihara Sangyo Kaisha Ltd Phenoxyalkylazole type compound and agricultural and gardening fungicide comprising it
GB2099818A (en) * 1981-06-06 1982-12-15 Pfizer Ltd Triazoles
EP0069442B1 (en) * 1981-06-06 1985-02-20 Pfizer Limited Antifungal agents, processes for their preparation, and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
KR840005134A (ko) 1984-11-03
ES523146A0 (es) 1984-10-01
AU542450B2 (en) 1985-02-21
AU1570283A (en) 1983-12-15
ATE24909T1 (de) 1987-01-15
CA1238909A (en) 1988-07-05
DE3369137D1 (en) 1987-02-19
IL68945A (en) 1986-09-30
JPS5962587A (ja) 1984-04-10
PT76846A (en) 1983-07-01
PT76846B (en) 1986-04-09
KR870000358B1 (ko) 1987-03-05
DK266083D0 (da) 1983-06-10
EP0097014A3 (en) 1984-07-25
ES8407488A1 (es) 1984-10-01
IL68945A0 (en) 1983-10-31
JPS6330308B2 (fi) 1988-06-17
EP0097014A2 (en) 1983-12-28
PH21493A (en) 1987-11-10
FI832101A0 (fi) 1983-06-10
FI74465C (fi) 1988-02-08
GR77534B (fi) 1984-09-24
US4510148A (en) 1985-04-09
FI74465B (fi) 1987-10-30
IE55233B1 (en) 1990-07-04
IE831371L (en) 1983-12-12
DK266083A (da) 1983-12-13
DK160825B (da) 1991-04-22
FI832101L (fi) 1983-12-13
EP0097014B1 (en) 1987-01-14

Similar Documents

Publication Publication Date Title
NO160138C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive((4-(4-(4-fenyl-1-piperazinyl)fenoksymetyl)-1,3-dioksolan-2-yl)-metyl)-1h-imidazoler og 1h-1,2,4-triazoler.
DK160825C (da) Analogifremgangsmaade til fremstilling af 2-(halogensubstitueret pyridyl)-1,3-bis(1h-1,2,4-triazol-1-yl)propan-2-ol-derivater eller farmaceutisk acceptable syreadditionssalte deraf
FI884625A0 (fi) Heterosyklisesti substituoidut atsolit ja atsiinit, menetelmät niiden valmistamiseksi ja niiden käyttö herbisideinä
NL7907583A (nl) Heterocyclische verbindingen, in het bijzonder indool- verbindingen, werkwijzen ter bereiding daarvan, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL8103768A (nl) Heterocyclische verbindingen, werkwijze ter bereiding daarvan, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL188578C (nl) 2-aryl-2-(1h-imidazol-1-yl-methyl of 1h-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-ylmethoxyfenylderivaat en farmaceutisch preparaat met werking tegen vaginale candidosis.
ATE61050T1 (de) Pyridazinamine wirksam gegen viren.
IE821285L (en) Triazole antifungal agents
NL7601296A (nl) Hydantoinederivaten en herbicide en/of fungicide preparaten alsmede werkwijze voor het bereiden daarvan.
IT1162458B (it) 1-(2-aril-4,5-bisostituiti)-1,3-diossolan-2-il-metil)-1h-imidazoli ed 1h-1,2,4-triazoli dotati di attivita' antimicrobica ed antifunghi e procedimento per la loro preparazione
MX162676A (es) Procedimiento para la preparacion de derivados de 2-(piridilalquensulfinii.)benzimidazoles n-substituidos
NL8402946A (nl) Antidepressieve 1,2,4-triazolon verbindingen; werkwijzen voor het bereiden daarvan; farmaceutische preparaten.
DK436387D0 (da) Triazol- eller imidazolgruppeholdige 2,5-dihydrofuran-derivater, fremgangsmaade til fremstilling deraf, mellemprodukter til brug ved fremstilling samt anvendelse af saadanne derivater som fungicider
DE2963929D1 (en) Heterocyclic derivatives of (4-(piperazin-1-yl-phenyloxymethyl)-1.3.-dioxolan-2-ylmethyl)-1h-imidazoles and -1h-1.2.4-triazoles, their preparation and use as fungicides and bactericides
NL950008I1 (nl) Topische preparaten voor het verlagen van de intraoculaire druk.
IT1220970B (it) Composti eteterociclici ad azione fungicida particolare per la lotta contro la candida albicans
NO158096C (no) Fremgangsmaate for fremstilling av terapeutisk aktivt (z)-1,2-difenyl-l-(4-(2-(n,n-dimetylamino)etoksylfenyl)-l-buten (i) eller tamoxifen og syreaddisjonssalter derav.
DK160094C (da) 2-imidazolylmethyl-3-difluorbenzyloxy-2,3-dihydro-fluor-benzo(b)thiophenderivater, analogifremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende disse forbindelser
MA19793A1 (fr) Procede de preparation de 1 - ( 1,3 - dioxolanne -2-yl "methyl) -1 h - imidazoles et -1h-1,2,4- triazoles utilisables en therapeutique .
ES511134A0 (es) "procedimiento de preparacion de nuevos derivados de la hidrazina, utiles como fungicidas y bactericidas".
EP0178682A3 (en) 1,3-bis(1h-1,2,4-triazol-1-yl)-2-fluoro-2-(2,4-difluorophenyl)propane, antifungal composition containing it, and process for preparation of the compound and the composition
DK156608C (da) Fungicidt middel indeholdende triazolylderivater samt fremgangsmaade til bekaempelse af svampe
DK157134C (da) Analogifremgangsmaade til fremstilling af 1-(5-chlorpyrid-2-yl)-1-(2,4-dihalogenphenyl)-2-(1,2,4-triazol-1-yl)-ethanol-forbindelser eller deres farmaceutisk acceptable syreadditionssalte
NL176328C (nl) Fungicidepreparaat, n-benzoyl-n'-halogeenalkylideenhydrazinen geschikt als werkzaam bestanddeel daarin, en werkwijze voor het bereiden daarvan.
BA97145B1 (bs) Postupak za dobivanje 2-(2,4 difluorofenil)-1,3-bis-(1H-1,2,4-tiazol-1-il)-propan-2-ola

Legal Events

Date Code Title Description
PBP Patent lapsed